9 results
PRE 14A
CCCC
C4 Therapeutics Inc
18 Apr 23
Preliminary proxy
7:59am
-founder of the Dana-Farber Innovations Research Fund, a venture philanthropy fund focused on early-stage research. From 1986 to 2006, Mr. Salter served
DEF 14A
CCCC
C4 Therapeutics Inc
26 Apr 21
Definitive proxy
4:22pm
Research Fund, a venture philanthropy fund focused on early-stage research. Mr. Cohen was co-founder and served as Chief Executive Officer … of the Dana-Farber Innovations Research Fund, a venture philanthropy fund focused on early-stage research. From 1986 to 2006, Mr. Salter served
424B4
bz02l517dlok5w9k84y
2 Oct 20
Prospectus supplement with pricing info
5:10pm
S-1/A
4ii1p3p uy
28 Sep 20
IPO registration (amended)
6:07am
S-1
1sdtl kdu
10 Sep 20
IPO registration
5:26pm
DRS
iyyd52 opiyd
6 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next